세계의 돼지용 백신 시장 리포트(2023년)

“Swine Vaccines Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on swine vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for swine vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The swine vaccines market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Attenuated Live Vaccines; Inactivated Vaccines; Subunit Vaccines; DNA (Deoxyribonucleic Acid) Vaccines; Recombinant Vaccines

• 2) By Disease: Viral Infections; Bacterial Infections; Parasitic Infection; Fungal Infections; Other Diseases

• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Pharmacies; Online Pharmacies

• 4) By Application: Government Tender; Market Sales

• Companies Mentioned: Merck & Co Inc; Boehringer Ingelheim; Elanco Animal Health Inc; Indian Immunologicals Limited; Biogenesis Bago SA

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the swine vaccines market are: Merck & Co Inc., Boehringer Ingelheim, Elanco Animal Health Inc., Indian Immunologicals Limited, Biogenesis Bago SA, Phibro Animal Health, KM Biologics, Hipra Laboratories SA, Ceva, Zoetis Inc., Jinyu Bio-Technology Co Ltd., China Animal Husbandry Industry Co Ltd., Shanghai Hile Bio-Technology Co Ltd., Ringpu Biology Technology Co Ltd., Chengdu Kanghua Biological Products Co Ltd., Choong Ang Vaccine Laboratories Co Ltd., Virbac, Harbin Veterinary Research Institute (HVRI), and Bioveta AS.

The global swine vaccines market is expected to grow from $1.83 billion in 2022 to $1.99 billion in 2023 at a compound annual growth rate (CAGR) of 8.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The swine vaccines market is expected to reach $2.71 billion in 2027 at a CAGR of 8%.

The swine vaccine market consists of sales of haemophilus parasuis, pasteurella, salmonella, and streptococcus suis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The swine vaccine refers to a preparation that is administered or injected in pigs to stimulate the immune response against a specific infectious agent.

North America was the largest region in the swine vaccines market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main product types of swine vaccines are attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA (deoxyribonucleic acid) vaccines, and recombinant vaccines. Attenuated live vaccines are made up of living viruses or bacteria that have undergone a process to weaken (attenuate) and diminish their pathogenicity. The attenuated live vaccine is a swine vaccine used to administer in pigs to multiply within the body to trigger a stronger antigenic stimulus, which results in long-lasting immunity. The diseases indicated are viral infections, bacterial infections, parasitic infections, fungal infections, and others. It is distributed through veterinary hospitals, veterinary pharmacies, and online pharmacies, which are provided through government tenders and market sales.

The rising prevalence of diseases in swine is expected to propel the swine vaccine market. Swine disease is any divergence from an organism's normal structural or functional condition accompanied by a few signs and symptoms of diseases such as pseudorabies, influenza. The demand for swine vaccines is increasing due to the rising prevalence of diseases in swine and the need to protect pigs from infectious diseases. For instance, in August 2022, according to the report by the World Organization for Animal Health (WAHIS), a global database of animal health, more than 1,125,000 pigs and 36,000 wild boars have been affected by African Swine Fever (ASF) since January 2020 (data reported through INs and FURs), resulting in more than 1,960,000 animal losses. Therefore, the rising prevalence of diseases in swine is expected to drive the market.

Technological advancement is a key trend gaining popularity in the swine vaccine market. Major players are concentrating their efforts on creating innovative technologies to deliver two vaccines at the same time to enhance swine health to sustain their position in the swine vaccine market. For example, in May 2022, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched TwistPak technology. TwistPak is a ground-breaking platform for blending two vaccines, IngelvacCircoFLEX and IngelvacMycoFLEX, for use by swine producers. TwistPak offers a convenient and short-time-consuming platform, enabling a simplified mixing process while maintaining the flexibility of using the products as a combined vaccine or a monovalent. It is manufactured using advanced technologies and is ergonomically designed.

In September 2021, Vaxxinova, a Germany-based producer of livestock vaccines, acquired Newport Laboratories from Boehringer Ingelheim for an undisclosed amount. This acquisition will help Vaxxinova develop and improve its goods and services for livestock farmers and veterinarians. Newport Laboratories is a US-based Newport Laboratories company that manufactures custom-made vaccines for swine and cattle.

The countries covered in the swine vaccines market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The swine vaccines market research report is one of a series of new reports from The Business Research Company that provides swine vaccines market statistics, including swine vaccines industry global market size, regional shares, competitors with a swine vaccines market share, detailed swine vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the swine vaccines industry. This swine vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Swine Vaccines Market Characteristics

3. Swine Vaccines Market Trends And Strategies

4. Swine Vaccines Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Swine Vaccines Market
• 4.2. Ukraine-Russia War Impact On Swine Vaccines Market
• 4.3. Impact Of High Inflation On Swine Vaccines Market

5. Swine Vaccines Market Size And Growth

• 5.1. Global Swine Vaccines Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Swine Vaccines Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Swine Vaccines Market Segmentation

• 6.1. Global Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA (Deoxyribonucleic Acid) Vaccines
• Recombinant Vaccines
• 6.2. Global Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Viral Infections
• Bacterial Infections
• Parasitic Infection
• Fungal Infections
• Other Diseases
• 6.3. Global Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Veterinary Hospitals
• Veterinary Pharmacies
• Online Pharmacies
• 6.4. Global Swine Vaccines Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Government Tender
• Market Sales

7. Swine Vaccines Market Regional And Country Analysis

• 7.1. Global Swine Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Swine Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Swine Vaccines Market

• 8.1. Asia-Pacific Swine Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Swine Vaccines Market

• 9.1. China Swine Vaccines Market Overview
• 9.2. China Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Swine Vaccines Market

• 10.1. India Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Swine Vaccines Market

• 11.1. Japan Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Swine Vaccines Market

• 12.1. Australia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Swine Vaccines Market

• 13.1. Indonesia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Swine Vaccines Market

• 14.1. South Korea Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Swine Vaccines Market

• 15.1. Western Europe Swine Vaccines Market Overview
• 15.2. Western Europe Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Swine Vaccines Market

• 16.1. UK Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Swine Vaccines Market

• 17.1. Germany Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Swine Vaccines Market

• 18.1. France Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Swine Vaccines Market

• 19.1. Eastern Europe Swine Vaccines Market Overview
• 19.2. Eastern Europe Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Swine Vaccines Market

• 20.1. Russia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Swine Vaccines Market

• 21.1. North America Swine Vaccines Market Overview
• 21.2. North America Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Swine Vaccines Market

• 22.1. USA Swine Vaccines Market Overview
• 22.2. USA Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Swine Vaccines Market

• 23.1. South America Swine Vaccines Market Overview
• 23.2. South America Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Swine Vaccines Market

• 24.1. Brazil Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Swine Vaccines Market

• 25.1. Middle East Swine Vaccines Market Overview
• 25.2. Middle East Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Swine Vaccines Market

• 26.1. Africa Swine Vaccines Market Overview
• 26.2. Africa Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Swine Vaccines Market Competitive Landscape And Company Profiles

• 27.1. Swine Vaccines Market Competitive Landscape
• 27.2. Swine Vaccines Market Company Profiles
  • 27.2.1. Merck & Co Inc
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Boehringer Ingelheim
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Elanco Animal Health Inc
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Indian Immunologicals Limited
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Biogenesis Bago SA
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Swine Vaccines Market

29. Swine Vaccines Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer